Skip to main content
SpringerLink
Log in

Alterations in the activity of phospholipases A2 in postmortem white matter from patients with multiple sclerosis

  • Original Articles
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Activities toward arachidonyl-labelled phospholipase A2 substrates were assayed in fractions of white matter and cerebral cortex from control subjects and in fractions of demyelinated plaque, normal-appearing white matter and cerebral cortex from subjects who died with multiple sclerosis. Membranous activity at pH 8.6 in the presence of Ca2+, characteristic of 14 kDa “secretory” phospholipase A2, in either multiple sclerosis white matter or cortex did not differ from controls, whereas membranous activity at pH 4.5 in the absence of added Ca2+, characteristic of lysosomal enzymes was increased over controls in both plaque and normal-appearing white matter but not cerebral cortex. Activity in the cytosol fraction, at pH 8.6 in the presence of Ca2+ and glycerol characteristic of the “cytosolic” 85 kDa enzyme was decreased by greater than 50% in both white matter and cortex samples from multiple sclerosis subjects. Immuno-precipitation and-blotting confirmed that the deficient activity was largely attributable to the 85 kDa enzyme although the enzyme protein was not similarly reduced.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Dennis, E. A., Rhee, S. G., Billah, M. M., and Hannun, Y. A. 1991. Role of phospholipases in generating lipid second messengers in signal transduction. FASEB J. 5:2068–2077.

    Google Scholar 

  2. Wong, P. Y.-K. and Dennis, E. A. (eds.), 1990. Phospholipase A2: Role and Function in Inflammation, Plenum Press, New York.

    Google Scholar 

  3. Mukherjee, A. B., (ed.), 1990. Biochemistry, Molecular Biology and Physiology of Phospholipase A2 and its Regulatory Factors, Plenum Press, New York.

    Google Scholar 

  4. Pruzanski, W., and Vadas, P. 1991. Phospholipase A2—a mediator between proximal and distal effectors of inflammation. Immunol. Today 12:143–146.

    Google Scholar 

  5. Waite, M. 1987. The Phospholipases (Handbook of lipid research; v. 5), pp. 1–332. Plenum Press, New York.

    Google Scholar 

  6. van den Bosch, H. 1982. Phospholipases. Pages 313–357,in Hawthorne, J. N. and Ansell, G. B. (eds.), Phospholipids (New Comprehensive Biochemistry Vol. 4), Elsevier Biomedical Press, Amsterdam.

    Google Scholar 

  7. Kudo, I., Murakami, M., Hara, S., and Inoue, K. 1993. Mammalian non-pancreatic phospholipases A2. Biochim. Biophys. Acta Lipids Lipid Metab. 1170:217–231.

    Google Scholar 

  8. Mayer, R. J., and Marshall, L. A. 1993. New insights on mammalian phospholipase A2(s); Comparison of arachidonoyl-selective and-nonselective enzymes. FASEB J. 7:339–348.

    Google Scholar 

  9. Hartung, H.-P., Jung, S., Stoll, G., Zielasek, J., Schmidt, B., Archelos, J. J., and Toyka, K. V. 1992. Inflammatory mediators in demyelinating disorders of the CNS and PNS. J. Neuroimmunol. 40:197–210.

    Google Scholar 

  10. Lassman, H., Zimprich, F., Rossler, K., and Vass, K. 1991. Inflammation in the nervous system: basic mechanisms and immunological concepts. Rev. Neurol. 147:763–781.

    Google Scholar 

  11. Perry, V. H., Andersson, P.-B., and Gordon, S. 1993. Macrophages and inflammation in the central nervous system. TINS 16:268–273.

    Google Scholar 

  12. Lin, L.-L., Lin, A. Y., and Knopf, J. L. 1992. Cytosolic phospholipase A2 is coupled to hormonally regulated release of arachidonic acid. Proc. Natl. Acad. Sci. USA 89:6147–6151.

    Google Scholar 

  13. Xing, M., and Mattera, R. 1992. Phosphorylation-dependent regulation of phospholipase A2 by G-proteins and Ca2+ in HL granulocytes. J. Biol. Chem. 267:25966–25975.

    Google Scholar 

  14. Lin, L.-L., Lin, A. Y., and DeWitt, D. L. 1992. Interleukin-1α induces the accumulation of cytosolic phospholipase A2 and the release of prostaglandin E2 in human fibroblasts. J. Biol. Chem. 267:23451–23454.

    Google Scholar 

  15. Kramer, R. M., Roberts, E. F., Manetta, J. V., Hyslop, P. A., and Jakubowski, J. A. 1993. Thrombin-induced phosphorylation and activation of Ca2+-sensitive cytosolic phospholipase A2 in human platelets. J. Biol. Chem. 268:26796–26804.

    Google Scholar 

  16. Sanders, V., Conrad, A. J., and Tourtellotte, W. W. 1993. On classification of post-mortem multiple sclerosis plaques for neuroscientists. J. Neuroimmunol. 46:207–216.

    Google Scholar 

  17. Norton, W. T., and Cammer, W. 1984. Chemical pathology of diseases involving myelin. Pages 369–403,in Morell, P. (ed.), Myelin, Plenum Press, New York.

    Google Scholar 

  18. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265–275.

    Google Scholar 

  19. Bartlett, G. R. 1959. Phosphorus assay in column chromatography. J. Biol. Chem. 234:466–468.

    Google Scholar 

  20. Waite, M. 1990. Phospholipases, enzymes that share a substrate class. Pages 1–22,in Mukherjee, A. B. (ed.) Biochemistry, molecular biology, and physiology of phospholipase A2 and its regulatory factors, (Adv. Exp. Med. Biol. 279), Plenum Press, New York.

    Google Scholar 

  21. Elsbach, P., and Weiss, J. 1991. Utilization of Escherichia coli as phospholipase substrate. Methods Enzymol. 197:24–30.

    Google Scholar 

  22. Folch, J., Lees, M., and Sloane Stanley, G. H. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:497–509.

    Google Scholar 

  23. Kramer, R. M., Roberts, E. F., Manetta, J., and Putnam, J. E. 1991. The Ca2+-sensitive cytosolic phospholipase A2 is a 100-kDa protein in human monoblast U937 cells. J. Biol. Chem. 266:5268–5272.

    Google Scholar 

  24. Leslie, C. C. 1991. Kinetic properties of a high molecular mass arachidonoyl-hydrolyzing phospholipase A2 that exhibits lysophospholipase activity. J. Biol. Chem. 266:11366–11371.

    Google Scholar 

  25. Clark, J. D., Lin, L.-L., Kriz, R. W., Ramesha, C. S., Sultzman, L. A., Lin, A. Y., Milona, N., and Knopf, J. L. 1991. A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP. Cell 65:1043–1051.

    Google Scholar 

  26. Clark, J. D., Milona, N., and Knopf, J. L. 1990. Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic line U937. Proc. Natl. Acad. Sci. USA 87:7708–7712.

    Google Scholar 

  27. Kim, D. K., and Bonventre, J. V. 1993. Purification of a 100 kDa phospholipase A2 from spleen, lung and kidney: Antiserum raised to pig spleen phospholipase A2 recognizes a similar form in bovine lung, kidney and platelets, and immunoprecipitates phospholipase A2 activity. Biochem. J. 294:261–270.

    Google Scholar 

  28. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685.

    Google Scholar 

  29. Bazan, N. G., Murphy, M. G., and Toffano, G. (eds.), 1992. Neurobiology of Essential Fatty Acids, (Adv. Exp. Med. Biol. Vol. 318), Plenum Press, New York.

    Google Scholar 

  30. Lumsden, C. E. 1965. Amino acids, intermediate carbohydrate metabolism and enzymes in multiple sclerosis. Pages 300–323,in McAlpine, D., Lumsden, C. E. and Acheson, E. D. (eds.), Multiple Sclerosis—a Reappraisal, E. & S. Livingstone, London.

    Google Scholar 

  31. Cooper, M. F., and Webster, G. R. 1970. The differentiation of phospholipase A1 and A2 in rat and human nervous tissue. J. Neurochem. 17:1543–1554.

    Google Scholar 

  32. Woelk, H., and Peiler Ichikawa, K. 1974. [On the activity of phospholipase A2 compared with 1-alk-1′-enyl-2-acyl-and 1-alkyl-2-acyl-glycerophosphatides in multiple sclerosis (author's transl)]. J. Neurol. 207:319–326.

    Google Scholar 

  33. Gray, N. C. C., and Strickland, K. P. 1982. The purification and characterization of phospholipase A2 activity from the 106,000 g pellet (microsomal fraction) of bovine brain acting on phosphatidylinositol. Can. J. Biochem. 60:108–117.

    Google Scholar 

  34. Gray, N. C. C., and Strickland, K. P. 1982. On the specificity of a phospholipase A2 from the 106000×g pellet of bovine brain. Lipids 17:91–96.

    Google Scholar 

  35. Rordorf, G., Uemura, Y., and Bonventre, J. V. 1991. Characterization of phospholipase A2 (PLA2) activity in gerbil brain: Enhanced activities of cytosolic, mitochondrial, and microsomal forms after ischemia and reperfusion. J. Neurosci. 11:1829–1836.

    Google Scholar 

  36. Yoshihara, Y., and Watanabe, Y. 1990. Translocation of phospholipase A2 from cytosol to membranes in rat brain induced by calcium ions. Biochem. Biophys. Res. Commun. 170:484–490.

    Google Scholar 

  37. Oka, S., and Arita, H. 1991. Inflammatory factors stimulate expression of Group II phospholipase A2 in rat cultured astrocytes. J. Biol. Chem. 266:9956–9960.

    Google Scholar 

  38. Hirashima, Y., Mills, J. S., Yates, A. J., and Horrocks, L. A. 1990. Phospholipase A2 activities with a plasmalogen substrate in brain and in neural tumor cells: a sensitive and specific assay using pyrenesulfonyl-labelled plasmenylethanolamine. Biochim. Biophys. Acta 1047:35–40.

    Google Scholar 

  39. Hirashima, Y., Farooqui, A. A., Mills, J. S., and Horrocks, L. A. 1992. Identification and purification of calcium-independent phospholipase A2 from bovine brain cytosol. J. Neurochem. 59:708–714.

    Google Scholar 

  40. Schalkwijk, C. G., Marki, F., and Bosch, H. van den. 1990. Studies on the acyl-chain selectivity of cellular phospholipases A2. Biochim. Biophys. Acta 1044:139–146.

    Google Scholar 

  41. Peters-Golden, M., and McNish, R. W. 1993. Redistribution of 5-lipoxygenase and cytosolic phospholipase A2 to the nuclear fraction upon macrophage activation. Biochem. Biophys. Res. Commun. 196:147–153.

    Google Scholar 

  42. Franson, R. C., Waite, M., and La Via, M. 1971. Identification of phospholipase A1 and A2 in the soluble fraction of rat liver lysosomes. Biochemistry 10:1942–1946.

    Google Scholar 

  43. Wightman, P. D., Humes, J. L., Davies, P., and Bonney, R. J. 1981. Identification and characterization of two phospholipase A2 activities in resident mouse peritoneal macrophages. Biochem. J. 195:427–433.

    Google Scholar 

  44. Hirsh, H. E. 1976. The qualitative histochemistry of multiple sclerosis plaques: acid proteinase and other acid hydrolases. J. Neurochem. 26:505–512.

    Google Scholar 

  45. Shah, S., and Johnson, R. C. 1980. Activity levels of cholestenol ester metabolizing enzymes in brain in multiple sclerosis: correlations with cholesterol ester concentrations. Exp. Neurol. 68:601–604.

    Google Scholar 

  46. Chu, S.-T., Chu, C.-C., Tseng, C.-C., and Chen, Y.-H. 1993. Met-8 of the β1bungarotoxin phospholipase A2 subunit is essential for the phospholipase A2-independent neurotoxic effect. Biochem. J. 295:713–718.

    Google Scholar 

  47. Woelk, H., jakumeit Morgott, U., and Schenck, K. 1976. Phospholipid metabolism in subacute sclerosing panencephalitis: activity of brain phospholipase A2 towards specifically labelled 1,2-diacyl-,1-alk-1′-enyl-2-acyl- and 1-alkyl-2-acyl-sn-glycero-3-phosphorycholine. J. Neurochem. 26:275–279.

    Google Scholar 

  48. Woelk, H., Kanig, K., and Peiler Ichikawa, K. 1974. Phospholipid metabolism in experimental allergic encephalomyelitis: activity of mitochondrial phospholipase A2 of rat brain towards specifically labelled 1,2-diacyl-,1-alk-1′-enyl-2-acyl- and 1-alkyl-2-acyl-sn-glycero-3-phosphorycholine. J. Neurochem. 23:745–750.

    Google Scholar 

  49. Fu, S. C., Mozzi, R., Krakowa, S., Higgins, R. J., and Horrocks, L. A. 1980. Plasmalogenase and phospholipase A1, A2 and L1 activities in white matter in canine distemper virus-associated demyelinating encephalitis. Acta Neuropathol. (Berl) 49:13–18.

    Google Scholar 

  50. Yoshihara, Y., Yamaji, M., Kawasaki, M., and Watanabe, Y. 1992. Ontogeny of cytosolic phospholipase A2 activity in rat brain. Biochem. Biophys. Res. Commun. 185:350–355.

    Google Scholar 

  51. Sharp, J. D., White, D. L., Chiou, X. G., Goodson, T., Gamboa, G. C., McLure, D., Burgett, S., Hoskins, J., Skakrud, P. L., Sportsman, J. R., Becker, G. W., Kang, L. H., Roberts, E. F., and Kramer, R. M. 1991. Molecular cloning and expression of human Ca2+-sensitive cytosolic phospholipase A2. J. Biol. Chem. 266:14850–14853.

    Google Scholar 

  52. Wijkander, J., and Sundler, R. 1992. Regulation of arachidonatemobilizing phospholipase A2 by phosphorylation via protein kinase C in macrophages. FEBS Lett. 311:299–301.

    Google Scholar 

  53. Hoeck, W. G., Ramesha, C. S., Chang, D. J., Fan, N., and Heller, R. A. 1993. Cytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor: Dexamethasone blocks the induced synthesis. Proc. Natl. Acad. Sci. USA 90:4475–4479.

    Google Scholar 

  54. Murakami, M., Kudo, I., and Inoue, K. 1993. Molecular nature of phospholipases A2 involved in prostaglandin I2 synthesis in human umbilical vein endothelial cells. J. Biol. Chem. 268:839–844.

    Google Scholar 

  55. Ramesha, C. S., and Ives, D. L. 1993. Detection of arachidonoylselective phospholipase A2 in human neutrophil cytosol. Biochim. Biophys. Acta Lipids Lipid Metab. 1168:37–44.

    Google Scholar 

  56. Bever, C. T., and Whittaker, J. N. 1985. Proteinases in inflammatory demyelinating disease. Springer Semin. Immunopathol. 8:235–250.

    Google Scholar 

  57. Ebers, G. C., and Sadovnick, A. D. 1993. The role of genetic factors in multiple sclerosis susceptibility. J. Neuroimmunol. 54:1–17.

    Google Scholar 

  58. Oksenberg, J. R., Begovich, A. B., Erlich, H. A., and Steinman, L. 1993. Genetic factors in multiple sclerosis. JAMA 270:2362–2369.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Neurology, University of Toronto, 6368 Medical Sciences Building, Taddle Creek Road, M5S 1A8, Toronto, Ontario, Canada

    S. Julia Huterer & John R. Wherrett

  2. Department of Neurology, University of California, Los Angeles, California

    Wallace W. Tourtellotte

Authors
  1. S. Julia Huterer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wallace W. Tourtellotte
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John R. Wherrett
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Special issue dedicated to Dr. Leon S. Wolfe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huterer, S.J., Tourtellotte, W.W. & Wherrett, J.R. Alterations in the activity of phospholipases A2 in postmortem white matter from patients with multiple sclerosis. Neurochem Res 20, 1335–1343 (1995). https://doi.org/10.1007/BF00992509

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00992509

Key Words

Search

Navigation